Microbot Medical Inc Share Price Nasdaq
Equities
US59503A1051
Biotechnology & Medical Research
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 12.67M 1.06B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.32% |
Managers | Title | Age | Since |
---|---|---|---|
Harel Gadot
CEO | Chief Executive Officer | 52 | 02/88/02 |
Rachel Vaknin
DFI | Director of Finance/CFO | 45 | 01/22/01 |
Chief Tech/Sci/R&D Officer | - | 01/12 |
Members of the board | Title | Age | Since |
---|---|---|---|
Scott Burell
BRD | Director/Board Member | 59 | 28/16/28 |
Director/Board Member | 66 | 12/17/12 | |
Tal Wenderow
BRD | Director/Board Member | 50 | 01/20/01 |
1st Jan change | Capi. | |
---|---|---|
+1.44% | 42.75B | |
+47.70% | 41.61B | |
+12.32% | 41.34B | |
-8.83% | 26.59B | |
+6.77% | 25.49B | |
-23.02% | 18.12B | |
+30.20% | 12.24B | |
-2.45% | 11.76B | |
+8.65% | 11B |